monascus extract hamilelikte güvenli mi?

Hamilelikte monascus extract yerine kullanılabilecek güvenli alternatifler | VeriMom

Related ingredients

Frequently asked questions

monascus extract hamilelikte güvenli mi?

Monascus extracts commonly contain monacolin K, which EFSA and other assessments treat as identical to lovastatin; statins have documented developmental/embryofetal concerns in animal studies and are clinically contraindicated or advised against in pregnancy—this supports a suspected reproductive hazard (h=2). The mechanism (HMG‑CoA reductase inhibition altering cholesterol biosynthesis needed for fetal development) is demonstrated (m=2). Topical cosmetic exposure is likely low but measurable (e=1). Sources: EFSA/scientific opinion on monacolins, FDA/statin pregnancy communications, and statin pregnancy reviews.

monascus extract emzirirken güvenli mi?

Because monacolin K = lovastatin and statins have been advised against in breastfeeding (potential for infant exposure and drug effects), the same suspected hazard (h=2) and demonstrated mechanism (m=2) apply. Topical absorption from cosmetics is expected to be low but measurable (e=1). Clinical/regulatory guidance recommends avoiding statins in breastfeeding. Sources: FDA statements and clinical reviews.

monascus extract bebek cildi için güvenli mi?

Do not increase hazard or mechanism absent infant‑specific toxicology, but exposure (e) is increased by +1 for infants due to immature skin barrier/higher surface‑area‑to‑weight. Thus e=2 when an extract contains absorbable monacolin K. Additionally, contamination risk with citrinin (a nephrotoxic mycotoxin) in some Monascus products is relevant for infant safety.

VeriMom monascus extract nasıl puanlıyor?

VeriMom monascus extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 40/100 (orta risk) olarak puanlar.

Hamilelikte monascus extract yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.